Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin
Peptide modification is used to optimize the transport of saporin specifically to cancer cells in vitro and in vivo, where it exerts anti-cancer actions.
Main Authors: | Curtis A. Allred, Claire Gormley, Indu Venugopal, Shunzi Li, Michael J. McGuire, Kathlynn C. Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-01-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-022-04385-7 |
Similar Items
-
190 Utilizing a peptide-based approach to target and evaluate novel biomarker Neu5Gc Sialyl Lewis A in cancer
by: Indu Venugopal, et al.
Published: (2023-11-01) -
A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density.
by: Bethany Powell Gray, et al.
Published: (2013-01-01) -
839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors
by: Amanda G Powell, et al.
Published: (2023-11-01) -
Towards Intracellular Delivery of Peptides
by: Andreas L. Marzinzik, et al.
Published: (2013-12-01) -
Effect of the T-domain on intracellular transport of diphtheria toxin
by: А. J. Labyntsev, et al.
Published: (2014-06-01)